1. 方法論と範囲
1.1. 調査方法
1.2. 調査目的と調査範囲
2. 定義と概要
3. エグゼクティブ・サマリー
3.1. 製品タイプ別スニペット
3.2. 技術別スニペット
3.3. エンドユーザー別スニペット
3.4. 地域別スニペット
4. ダイナミクス
4.1. 影響要因
4.1.1. 推進要因
4.1.1.1. 痛みのない代替品への需要の増加
4.1.1.2. XX
4.1.2. 阻害要因
4.1.2.1. デバイスの高コスト
4.1.3. 機会
4.1.4. 影響分析
5. 産業分析
5.1. ポーターのファイブフォース分析
5.2. サプライチェーン分析
5.3. 価格分析
5.4. 規制分析
6. 製品タイプ別
6.1. 製品紹介
6.1.1. 市場規模分析および前年比成長率分析（%）, 製品タイプ別
6.1.2. 市場魅力度指数（製品タイプ別
6.2. ハンドヘルド機器
6.2.1. はじめに
6.2.2. 市場規模分析と前年比成長率分析(%)
6.3. ウェアラブルデバイス
7. 技術別
7.1. はじめに
7.1.1. 市場規模分析および前年比成長率分析（%）, 技術別
7.1.2. 市場魅力度指数、技術別
7.2. 静脈穿刺
7.2.1. 導入
7.2.2. 市場規模分析と前年比成長率分析(%)
7.3. タッチベース
8. エンドユーザー別
8.1. 導入
8.1.1. 市場規模分析および前年比成長率分析(%), エンドユーザー別
8.1.2. 市場魅力度指数、エンドユーザー別
8.2. 病院
8.2.1. はじめに
8.2.2. 市場規模分析と前年比成長率分析(%)
8.3. 外来手術センター
8.4. 診断研究所
8.5. その他
9. 地域別
9.1. はじめに
9.1.1. 地域別市場規模分析および前年比成長率分析(%)
9.1.2. 市場魅力度指数、地域別
9.2. 北米
9.2.1. 序論
9.2.2. 主な地域別ダイナミクス
9.2.3. 市場規模分析および前年比成長率分析（%）, 製品タイプ別
9.2.4. 市場規模分析およびYoY成長率分析（%）, 技術別
9.2.5. 市場規模分析および前年比成長率分析(%)、エンドユーザー別
9.2.6. 市場規模分析および前年比成長率分析(%)、国別
9.2.6.1. 米国
9.2.6.2. カナダ
9.2.6.3. メキシコ
9.3. ヨーロッパ
9.3.1. はじめに
9.3.2. 主な地域別動向
9.3.3. 市場規模分析および前年比成長率分析（%）, 製品タイプ別
9.3.4. 市場規模分析およびYoY成長率分析（%）, 技術別
9.3.5. 市場規模分析および前年比成長率分析(%)、エンドユーザー別
9.3.6. 市場規模分析および前年比成長率分析(%)、国別
9.3.6.1. ドイツ
9.3.6.2. イギリス
9.3.6.3. フランス
9.3.6.4. スペイン
9.3.6.5. イタリア
9.3.6.6. その他のヨーロッパ
9.4. 南米
9.4.1. はじめに
9.4.2. 地域別主要市場
9.4.3. 市場規模分析および前年比成長率分析（%）, 製品タイプ別
9.4.4. 市場規模分析およびYoY成長率分析（%）, 技術別
9.4.5. 市場規模分析および前年比成長率分析 (%)、エンドユーザー別
9.4.6. 市場規模分析および前年比成長率分析(%)、国別
9.4.6.1. ブラジル
9.4.6.2. アルゼンチン
9.4.6.3. その他の南米諸国
9.5. アジア太平洋
9.5.1. はじめに
9.5.2. 主な地域別ダイナミクス
9.5.3. 市場規模分析および前年比成長率分析（%）, 製品タイプ別
9.5.4. 市場規模分析とYoY成長率分析（%）, 技術別
9.5.5. 市場規模分析および前年比成長率分析 (%)、エンドユーザー別
9.5.6. 市場規模分析および前年比成長率分析（%）, 国別
9.5.6.1. 中国
9.5.6.2. インド
9.5.6.3. 日本
9.5.6.4. 韓国
9.5.6.5. その他のアジア太平洋地域
9.6. 中東・アフリカ
9.6.1. 序論
9.6.2. 主な地域別ダイナミクス
9.6.3. 市場規模分析および前年比成長率分析（%）, 製品タイプ別
9.6.4. 市場規模分析とYoY成長率分析（%）, 技術別
9.6.5. 市場規模分析および前年比成長率分析(%)、エンドユーザー別
10. 競合情勢
10.1. 競争シナリオ
10.2. 市場ポジショニング／シェア分析
10.3. M&A分析
11. 企業プロフィール
11.1. Becton, Dickinson and Company (BD) *
11.1.1. 会社概要
11.1.2. 製品ポートフォリオと内容
11.1.3. 財務概要
11.1.4. 主な展開
11.2. YourBio Health, Inc.
11.3. Tasso, Inc.
11.4. Romsons
11.5. AlphaBiolabs Ltd
11.6. Loop Medical SA.
11.7. Utah Medical Products, Inc.
11.8. ICU Medical, Inc.
11.9. Winnoz Technology, Inc. (*リストはありません)
12. 付録
12.1. 会社概要とサービス
12.2. お問い合わせ
The Global Needle Free Blood Drawing Devices Market reached US$ 14.43 billion in 2023 and is expected to reach US$ 26.52 billion by 2031 growing with a CAGR of 7.9% during the forecast period 2024-2031.
Needle-free blood drawing devices offer a painless alternative to conventional blood collection methods that rely on needles and syringes. These devices launch a micro-particle into the skin, creating a tiny opening that allows blood to be extracted using negative pressure. This innovative technique greatly diminishes patient discomfort and lowers the likelihood of needle-stick injuries, a common issue associated with traditional blood collection methods.
The primary benefit of needle-free devices lies in their capacity to alleviate the pain associated with blood draws, addressing a significant concern for numerous patients. These devices significantly diminish the likelihood of needle-stick injuries among healthcare professionals, thereby reducing the risk of transmitting blood-borne pathogens.
Many needle-free devices are crafted to be intuitive and straightforward, making them suitable for use in home environments, which can improve patient adherence to regular health monitoring. These devices frequently utilize cutting-edge technologies, such as micro-particle propulsion or capillary action, to enable blood collection without the need for traditional needles.
Market Dynamics: Drivers
Increasing demand for pain-free alternatives
The demand for the global needle-free blood drawing devices market is driven by multiple factors. One of the primary factors is the increasing demand for pain-free alternatives. The growing preference for needle-free blood drawing devices in the U.S. is largely driven by the desire for less painful medical procedures, particularly among patients who experience anxiety or discomfort with traditional needle-based methods. This trend is significant in hospitals where a high volume of blood draws occurs, impacting clinical decisions and patient care.
Conventional blood collection techniques, like venipuncture, frequently cause considerable pain and anxiety for patients. This discomfort stems from the process of inserting needles into the skin and veins, which can be especially troubling for individuals who have a fear of needles or for those who need to undergo blood draws regularly.
Moreover, key players in the industry more focus on technological advancements that help to propel this market growth. For instance, in April 2022, the Haiim device, developed by Winnoz Technology, represents a significant advancement in blood collection methods by offering a needle-free alternative to traditional venipuncture. This innovative device is designed to collect blood samples from the fingertips, utilizing vacuum-assisted technology to draw between 150 and 500 microliters of whole blood quickly and less painfully.
Also, in February 2022, Tasso, Inc. launched Tasso Care for Prescreening, a comprehensive service solution designed to enhance the prescreening process for clinical trials. This service aims to streamline the recruitment of participants by utilizing Tasso's innovative remote blood collection technology, which is patient-centric and clinically validated.
Restraints
Factors such as the high cost of devices, limited availability of devices, and limited reimbursement policies are expected to hamper the market.
Market Segment Analysis
The global needle-free blood drawing devices market is segmented based on product type, technology, end-user, and region.
The hospital's segment accounted for approximately 65.6% of the global needle-free blood drawing devices market share
The hospital segment is expected to hold the largest market share over the forecast period. The rising frequency of blood draws conducted each year in the U.S. is fueling the demand for needle-free alternatives. In hospitals, numerous patients may require several blood draws each day, and challenges such as difficult venous access often due to obesity, age, or underlying health conditions are increasing the necessity for needle-free solutions. Hospitals play a vital role in the healthcare industry, affecting as much as 70% of clinical decisions, which underscores the importance of effective blood collection methods.
Moreover, key player’s product launches & approvals and innovative technological developments are driving this segment’s growth in this market. For instance, in November 2023, BD (Becton, Dickinson and Company) launched the PIVO Pro Needle-free Blood Collection Device after receiving 510(k) clearance from the U.S. Food and Drug Administration (FDA). This new device is designed to work with integrated catheters and aims to advance BD's vision of a "One-Stick Hospital Stay."
Similarly, YourBio Health developed the HALO Technology, created by significantly improving the blood collection process by using a patented bladeless microneedle array, which facilitates nearly painless blood draws. Also, in April 2024, the 1st generation TAP (Touch Activated Phlebotomy) device developed by YourBio Health represented a significant breakthrough in blood collection technology. It offered an easy-to-use, virtually painless alternative to traditional blood draws, making it suitable for clinical and remote clinical settings.
Market Geographical Analysis
North America accounted for approximately 46.2% of the global needle-free blood drawing devices market share
North America region is expected to hold the largest market share over the forecast period owing to the increasing demand for pain-free alternatives and a high volume of blood draws that would propel this market growth in the U.S.
Moreover, Approval from regulatory agencies such as the FDA is crucial for the promotion and utilization of needle-free blood drawing devices in the United States. Companies that can secure these approvals, like BD with its PIVO device, are positioned to gain a competitive advantage in the marketplace. In this region, a major number of key players’ presence, technological advancements, well-advanced healthcare infrastructure, product launches & approvals, and government initiatives such as awareness programs, partnerships & collaborations are driving this market growth.
For instance, in December 2023, BD (Becton, Dickinson and Company) received 510(k) clearances from the U.S. Food and Drug Administration (FDA) for its new BD MiniDraw Capillary Blood Collection System. This innovative fingertip blood collection device is designed to collect blood samples through a fingerstick, providing a less invasive alternative to traditional venous blood draws. The system allows trained healthcare professionals to obtain lab-quality results from a smaller volume of blood, making it suitable for various common tests.
Also, in October 2022, Catapult Health and Tasso partnered to integrate the Tasso+ self-sampling blood collection device into annual healthcare checkups for employees at major corporations and national health plans in the USA. This collaboration aims to enhance the efficiency and comfort of blood testing during routine health assessments.
Market Segmentation
By Product Type
Handheld Devices
Wearable Devices
By Technology
Venipuncture
Touch-Based
By End-Users
Hospitals
Ambulatory Surgical Centers
Diagnostic Laboratories
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
U.K.
France
Spain
Italy
Rest of Europe
South America
Brazil
Argentina
The rest of South America
Asia-Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
Middle East and Africa
Market Competitive Landscape
The major global players in the needle-free blood drawing devices market include Becton, Dickinson and Company (BD), YourBio Health, Inc., Tasso, Inc., Romsons, AlphaBiolabs Ltd, Loop Medical SA., Utah Medical Products, Inc., ICU Medical, Inc., and Winnoz Technology, Inc.
Key Developments
In November 2023, BD introduced the PIVO Pro Needle-free Blood Collection Device, which allows blood samples to be drawn directly from a patient's peripheral IV line without using a traditional needle. This innovative device builds upon BD's existing PIVO technology that was first introduced for use with short peripheral IV catheters. The PIVO Pro is designed to be compatible with integrated catheters, including the new Nexiva Closed IV Catheter System with NearPort V Access
In March 2022, Vitestro launched an autonomous blood collection device designed to empower patients by allowing them to participate actively in their blood draw procedures. This innovative venipuncture device utilizes advanced technology, including artificial intelligence and ultrasound-guided imaging, combined with robotic needle insertion, to automate the blood collection process.
Why Purchase the Report?
To visualize the global needle-free blood drawing devices
Market Segmentation based on product type, technology, end-user, and region and understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of the needle-free blood drawing devices market with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping is available in excel consisting of key products of all the major players.
The global needle-free blood drawing devices market report would provide approximately 59 tables, 50 figures, and 184 pages.
Target Audience 2024
Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies
1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product type
3.2. Snippet by Technology
3.3. Snippet by End-User
3.4. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing Demand for Pain-Free Alternatives
4.1.1.2. XX
4.1.2. Restraints
4.1.2.1. High Cost of Devices
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
6. By Product type
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
6.1.2. Market Attractiveness Index, By Product Type
6.2. Handheld Devices *
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Wearable Devices
7. By Technology
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
7.1.2. Market Attractiveness Index, By Technology
7.2. Venipuncture *
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Touch-Based
8. By End-User
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.1.2. Market Attractiveness Index, By End-User
8.2. Hospitals *
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Ambulatory Surgical Centers
8.4. Diagnostic Laboratories
8.5. Others
9. By Region
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.2.6.1. U.S.
9.2.6.2. Canada
9.2.6.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.3.6.1. Germany
9.3.6.2. U.K.
9.3.6.3. France
9.3.6.4. Spain
9.3.6.5. Italy
9.3.6.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.4.6.1. Brazil
9.4.6.2. Argentina
9.4.6.3. Rest of South America
9.5. Asia-Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.5.6.1. China
9.5.6.2. India
9.5.6.3. Japan
9.5.6.4. South Korea
9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10. Competitive Landscape
10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis
11. Company Profiles
11.1. Becton, Dickinson and Company (BD) *
11.1.1. Company Overview
11.1.2. Product Portfolio and Description
11.1.3. Financial Overview
11.1.4. Key Developments
11.2. YourBio Health, Inc.
11.3. Tasso, Inc.
11.4. Romsons
11.5. AlphaBiolabs Ltd
11.6. Loop Medical SA.
11.7. Utah Medical Products, Inc.
11.8. ICU Medical, Inc.
11.9. Winnoz Technology, Inc. (*LIST NOT EXHAUSTIVE)
12. Appendix
12.1. About Us and Services
12.2. Contact Us
| ※参考情報 針なし採血器具とは、従来の針を使用せずに血液を採取するためのデバイスです。これらの器具は、患者に対する痛みや不快感を軽減することを目的としており、特に小児や高齢者、血液採取に対して不安を持つ人々にとって利用が注目されています。 針なし採血器具にはいくつかの種類があります。一般的なものとしては、ジェットインジェクターと呼ばれるデバイスがあります。これは高圧の液体を使用して皮膚を貫通させ、血液を採取する仕組みです。また、マイクロニードル技術を使用した器具もあります。この技術では、非常に小さな針を使用することで、ほとんど痛みを感じさせずに血液を採取します。 用途としては、血液検査が主なものです。血液検査は多くの病気の診断や治療のモニタリングに必須ですが、従来の方法では患者にとって負担が大きいことがありました。針なし採血器具は、特に繰り返しの採血を必要とする状況において、患者の負担を軽減し、血液サンプルの採取をスムーズに行える点で有用です。例えば、糖尿病患者が自己管理のために血糖値を頻繁に測定する際には、大きな利点となります。 さらに、針なし採血器具は医療機関における感染リスクの低減にも寄与します。従来の針を使用する場合、針刺し事故や感染症のリスクがつきものですが、針なし器具を利用することにより、これらのリスクを大幅に軽減することができます。これにより、医療従事者の安全性も向上します。 関連技術としては、バイオセンサー技術が注目されています。バイオセンサーは、血液中の特定のバイオマーカーを検出するためのデバイスであり、針なし採血器具と組み合わせることで、即時の診断やモニタリングが可能になります。これにより、患者の状態を迅速に把握し、適切な治療方針を立てることができるようになるのです。 また、インフラストラクチャーとしては、電子健康記録（EHR）システムとの統合も重要です。針なし採血器具から得られたデータをリアルタイムでEHRに反映させることで、医療情報が効率よく管理され、医療者と患者のコミュニケーションが向上します。これにより、患者の治療履歴や血液検査結果を一元管理できるため、長期的な健康管理が更に効率的になります。 針なし採血器具の市場は、急速に成長しています。市場の成長要因として、患者の痛みや不快感を軽減するニーズの増加や、感染症リスクの低減に対する関心の高まりが挙げられます。さらに、テクノロジーの進化に伴い、より高性能で使いやすいデバイスが開発されていることも市場を押し上げる要因です。 今後の展望としては、針なし採血器具がさらに一般的に普及し、医療現場において標準的な採血方法となる可能性があります。技術の進化や連携する医療機器の改善が進むことで、患者にとってより快適で安全な医療環境が実現することが期待されます。このような器具は、医療従事者にとっても効率的な作業を促進するため、双方にとって多くの利点があります。 総じて、針なし採血器具は、医療分野における重要な革新技術として位置づけられており、今後の発展が期待されます。患者の負担を軽減し、医療の質を向上させるための一助となるでしょう。 |
❖ 世界の針なし採血器具市場に関するよくある質問(FAQ) ❖
・針なし採血器具の世界市場規模は？
→DataM Intelligence社は2023年の針なし採血器具の世界市場規模を144億3,000万米ドルと推定しています。
・針なし採血器具の世界市場予測は？
→DataM Intelligence社は2031年の針なし採血器具の世界市場規模を265億2,000万米ドルと予測しています。
・針なし採血器具市場の成長率は？
→DataM Intelligence社は針なし採血器具の世界市場が2024年～2031年に年平均7.9%成長すると予測しています。
・世界の針なし採血器具市場における主要企業は？
→DataM Intelligence社は「Becton, Dickinson and Company (BD)、YourBio Health, Inc.、Tasso, Inc.、Romsons、AlphaBiolabs Ltd.、Loop Medical SA.、Utah Medical Products, Inc.、ICU Medical, Inc.、Winnoz Technology, Inc.など ...」をグローバル針なし採血器具市場の主要企業として認識しています。
※上記FAQの市場規模、市場予測、成長率、主要企業に関する情報は本レポートの概要を作成した時点での情報であり、納品レポートの情報と少し異なる場合があります。
